As the government shutdown stretches into its second week, the U.S. Food and Drug Administration (FDA) continues ...
Cybersecurity is no longer just a best-practice recommendation. Following the Food and Drug Omnibus Reform Act of ...
Artificial intelligence (AI) continues to revolutionize healthcare, transforming how data is interpreted, ...
This year’s RAPS Convergence 2025, held October 7–9 at the David L. Lawrence Convention Center in Pittsburgh, ...
Artificial intelligence is transforming every corner of the life sciences—and drug development is no exception. ...
The liver is one of the body’s most resilient organs. Every day, it works overtime to process alcohol, ...
Emerging research from the Karolinska Institutet underscores something most of us already suspect: quality sleep ...
While widely available, PSA testing has sparked ongoing discussion about its benefits and risks. Understanding how ...
EMMA International proudly announces the launch of its new Financial Services for Life Science Companies. This ...
At EMMA International, we understand that resilience isn’t just a business objective—it’s a personal one, too. In ...
The European regulatory landscape continues to evolve rapidly, with new initiatives aimed at balancing innovation, ...
The U.S. Food and Drug Administration (FDA) announced it will not accept regulatory submissions that require user ...